Authors : Chinakila J. Musonda; Brian Mukuka; Bislom C. Mweene; Benson M. Hamooya; Sepiso K. Masenga; Badisa John Phafane

Volume/Issue : Volume 11 - 2026, Issue 10 - October

Google Scholar : https://tinyurl.com/33extejh

DOI : https://doi.org/10.38124/ijisrt/26Oct1004

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: Diabetes mellitus is associated with increased cardiovascular morbidity, but the pattern of selected inflammatory and cardiac biomarkers among people with and without diabetes may vary across populations. This study compared selected biomarkers between participants with and without diabetes mellitus.  Methods: This cross-sectional comparative study included 133 clinic attendees in Gaborone, Botswana: 71 with diabetes and 62 without diabetes. Biomarkers measured were high-sensitivity C-reactive protein (hs-CRP), creatine kinase (CK), CK-MB, troponin I and N-terminal pro-B-type natriuretic peptide (NT-proBNP). Continuous variables were summarised using medians and interquartile ranges (IQRs) and compared using Mann–Whitney U tests. Holm adjustment was applied across five biomarker comparisons. Adjusted associations were examined using separate log-linear regression models for each biomarker, controlling for age, sex, recalculated body mass index and systolic blood pressure.

Keywords : Cardiovascular Biomarkers; Diabetes Mellitus; hs-CRP; Inflammation; NT-proBNP; Troponin I.

References :

1. Home, Resources, diabetes L with, Acknowledgement, FAQs, Contact, et al. 9th edition | IDF Diabetes Atlas [Internet]. [cited 2025 Jan 24]. Available from: https://diabetesatlas.org/atlas/ninth-edition/
2. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol [Internet]. 2018 Jun 8 [cited 2025 Jan 27];17:83. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994068/
3. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation [Internet]. 2020 Mar 3 [cited 2025 Jan 27];141(9):e139–596. Available from: https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000757
4. Libby P, Loscalzo J, Ridker P, Farkouh ME, Hsue PY, Fuster V, et al. Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J Am Coll Cardiol [Internet]. 2018 Oct 23 [cited 2025 Jan 27];72(17):2071–81. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196735/
5. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet [Internet]. 2010 Jun 26 [cited 2025 Jan 29];375(9733):2215–22. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904878/
6. Apple FS, Collinson PO, for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays. Clinical Chemistry [Internet]. 2012 Jan 1 [cited 2025 Jan 29];58(1):54–61. Available from: https://doi.org/10.1373/clinchem.2011.165795
7. Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. European Journal of Preventive Cardiology [Internet]. 2019 Dec 1 [cited 2025 Jan 31];26(2_suppl):25–32. Available from: https://doi.org/10.1177/2047487319878371
8. Willerson JT, Ridker PM. Inflammation as a Cardiovascular Risk Factor. Circulation [Internet]. 2004 Jun [cited 2025 Jan 29];109(21_suppl_1):II–2. Available from: https://www.ahajournals.org/doi/10.1161/01.CIR.0000129535.04194.38
9. Li L, Roumeliotis N, Sawamura T, Renier G. C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive protein-induced endothelial dysfunction. Circ Res. 2004 Oct 29;95(9):877–83.
10. Scherer PE, Hill JA. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium. Circ Res [Internet]. 2016 May 27 [cited 2025 Jan 31];118(11):1703–5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888905/
11. Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in Obesity, Diabetes and related Disorders. Immunity [Internet]. 2022 Jan 11 [cited 2025 Jan 29];55(1):31–55. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773457/
12. de Luca C, Olefsky JM. Inflammation and Insulin Resistance. FEBS Lett [Internet]. 2008 Jan 9 [cited 2025 Jan 29];582(1):97–105. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246086/
13. Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol [Internet]. 2020 Jan 29 [cited 2025 Jan 29];10:1607. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000657/
14. Matheus AS de M, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, Gomes M de B. Impact of Diabetes on Cardiovascular Disease: An Update. Int J Hypertens [Internet]. 2013 [cited 2025 Jan 30];2013:653789. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603160/
15. Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes [Internet]. 2015 Oct 10 [cited 2025 Jan 30];6(13):1246–58. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600176/
16. Borén J, Öörni K, Catapano AL. The link between diabetes and cardiovascular disease. Atherosclerosis [Internet]. 2024 Jul 1 [cited 2025 Jan 30];394. Available from: https://www.atherosclerosis-journal.com/article/S0021-9150(24)00167-9/fulltext
17. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol [Internet]. 2018 May [cited 2025 Jan 30];34(5):575–84. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953551/
18. Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes [Internet]. 2014 Aug 15 [cited 2025 Jan 30];5(4):444–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127581/
19. Hayfron-Benjamin CF, Maitland-van der Zee AH, van den Born BJ, Amoah AGB, Meeks KAC, Klipstein-Grobusch K, et al. Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: the RODAM study. BMJ Open Diabetes Res Care [Internet]. 2020 Jul 14 [cited 2025 Jan 31];8(1):e001235. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365428/
20. Bachmann KN, Wang TJ. Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes. Diabetologia [Internet]. 2018 May [cited 2025 Jan 31];61(5):987–95. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874155/